Catalent wins contract to manufacture AZD1222 COVID-19 vaccine candidate
US-based Catalent said that its subsidiary Catalent Biologics has bagged a contract to provide vial filling and packaging capacity to AstraZeneca at its manufacturing facility in Anagni, Italy, and prepare for large-scale commercial supply of AZD1222, the adenovirus vector based COVID-19 vaccine candidate of the University of Oxford. Catalent said that the agreement fast tracks […]